Showing all published months. Partner preview tables include up to 5 countries.
CSV orders from USD 9.90 ยท One-time purchase. Review coverage and your total before payment.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| Hong Kong | $1.6B | 25.0% |
| United States | $757.6M | 11.9% |
| India | $616M | 9.7% |
| Italy | $516.8M | 8.1% |
| Russia | $358.9M | 5.6% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| United States | $6.2M | 21.0% |
| Russia | $4.3M | 14.4% |
| India | $3.2M | 10.9% |
| Hong Kong | $2.8M | 9.4% |
| Japan | $2M | 6.7% |
| Year | Export value |
|---|---|
| 2021 | $1.8B |
| 2022 | $1.8B |
| 2023 | $1.1B |
| 2024 | $796.3M |
| 2025 | $585.2M |
| 2026 | $318.6M |
China customs reports HS 300190 at the 8-digit level. 2 subheadings are published under it, and export values for each are available on request.
Anticoagulant glycosaminoglycan extracted from animal tissues, specifically encompassing heparin and its chemically derived salts for therapeutic applications.
Preparations of human or animal origin intended for therapeutic or prophylactic uses, capturing those substances not elsewhere specified or classified as heparin.
Public data shows up to 5 partner countries. Buy monthly partner trade values in CSV; choose HS8 for native quantity and unit fields where published.
CSV orders from USD 9.90 ยท One-time purchase. Confirm available coverage and your total in the order preview before paying.
Download after payment. Large packages may need preparation; delivery timing is confirmed before checkout.
Need help choosing products or regular updates? Ask us for a quote by email.
Sample files illustrate the delivery format. Preview your selected scope in the order builder.
HS 300190 is also written 3001.90. Values are in USD; the public series does not report tonnes or kg. Product scope: Glands and other organs for organo-therapeutic uses, whether or not powdered; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses. The public page shows monthly export partner previews from official GACC customs statistics. Preview and buy a monthly CSV for your selected products, countries and years.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Glands and other organs (HS 300190) Export Data." https://chinadata.live/china-trade/hs/300190/
China exported $478M of glands and other organs in the twelve months to August 2026, averaging $39.8M per month, based on official China customs statistics (HS 300190).
Glands and other organs for organo-therapeutic uses, whether or not powdered; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses.
Hong Kong, United States and India together account for 47% of the published total, out of 58 trading partners on record.
Annual exports declined by 67% between 2021 and 2025, from $1.8B to $585M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available as a one-time CSV purchase. Choose your products and coverage, then preview the file and price before payment.